DBV Technologies (DBVT) Current Assets (2015 - 2026)
DBV Technologies (DBVT) posted quarterly Current Assets of $201.9 million for Q2 2026, up 66.53% year-on-year from $121.2 million in Q2 2025, and down 18.16% on a QoQ basis from $246.7 million in Q1 2026.
DBV Technologies (DBVT) Current Assets (2015 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Current Assets for 12 consecutive years, with $201.9 million the latest figure, recorded in Q2 2026.
- Quarterly Current Assets rose 66.53% year-over-year to $201.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $201.9 million (up 66.53% YoY) and the FY2025 annual result came in at $212.9 million, up 379.63% from the prior year.
- Current Assets retreated to $201.9 million in Q2 2026 per DBVT's latest filing, from $246.7 million in the prior quarter.
- Over the last five years, Current Assets for DBVT reached as high as $260.0 million in Q2 2022 and fell as low as $29.1 million in Q1 2025.
- A 5-year average of $153.1 million and a median of $164.1 million in 2023 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2025 — Current Assets slumped 75.62% — and 2026, when it surged 746.37%.
- Year by year, Current Assets stood at $223.1 million in 2022, then slipped by 28.76% to $158.9 million in 2023, then tumbled by 72.07% to $44.4 million in 2024, then surged by 379.63% to $212.9 million in 2025, then dropped by 5.17% to $201.9 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $201.9 million, $246.7 million, and $212.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | 201.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 201.90 Mn |
| Mar 31, 2026 | 246.70 Mn |
| Dec 31, 2025 | 212.90 Mn |
| Sep 30, 2025 | 88.88 Mn |
| Jun 30, 2025 | 121.24 Mn |
| Mar 31, 2025 | 29.15 Mn |
| Dec 31, 2024 | 44.39 Mn |
| Sep 30, 2024 | 68.76 Mn |
| Jun 30, 2024 | 89.96 Mn |
| Mar 31, 2024 | 119.56 Mn |
| Dec 31, 2023 | 158.92 Mn |
| Sep 30, 2023 | 169.27 Mn |
| Jun 30, 2023 | 195.54 Mn |
| Mar 31, 2023 | 210.24 Mn |
| Dec 31, 2022 | 223.07 Mn |
| Sep 30, 2022 | 225.70 Mn |
| Jun 30, 2022 | 259.95 Mn |
| Mar 31, 2022 | 90.44 Mn |
| Dec 31, 2021 | 114.39 Mn |
| Sep 30, 2021 | 110.14 Mn |